Thank you Mozz for taking the time and effort to do this.
PAR recently said they extended the agreement to cover additional clinical conditions, can they elaborate on this and how do they plan on approaching these opportunities given the current commitment to OA and MPS?
Have there been any interested parties in performing any research agreements for other clinical conditions? And if so what area / conditions where they interested in? (Probably commercial in confidence) particularly interested in if there was any research into Long Covid due to the success PAR has had with the twins.
Some anecdotal evidence that patients treated with iPPS have had significant weight loss (Liffort Hobley) any research gone into this?
not sure if my questions are appropriate, but as you know I do tend to ask some questions around this disease and that disease
- Forums
- ASX - By Stock
- PAR
- R & D Day Compilation of Questions Thread
R & D Day Compilation of Questions Thread, page-2
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
26.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $92.81M |
Open | High | Low | Value | Volume |
27.0¢ | 29.0¢ | 25.5¢ | $430.3K | 1.585M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5500 | 26.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
26.5¢ | 36162 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 61837 | 0.255 |
2 | 25200 | 0.250 |
1 | 15000 | 0.245 |
3 | 85000 | 0.240 |
1 | 8510 | 0.235 |
Price($) | Vol. | No. |
---|---|---|
0.265 | 583 | 1 |
0.270 | 25000 | 1 |
0.275 | 3350 | 1 |
0.285 | 46000 | 1 |
0.290 | 44274 | 3 |
Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |